Content
05/09/2024
Charlestown, MA USA
ArkeaBio
completed $26.5 million Series A Round funding. Investors include
Breakthrough Energy Ventures (lead), AgriZeroNZ, Grantham Foundation, Rabo Ventures, The51.
About
ArkeaBioTM is an ag-biotech start-up developing a safe, user-friendly, and cost-conscious vaccine to reduce ruminant methane emissions that will work seamlessly with existing global agribusiness practices.
Startup
Sector:
AgTech
Biotech
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
